About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Encapsulated Sclerosing Peritonitis Successfully Treated with Corticosteroid Therapy and Total Parental Nutrition
Anam Hanut1, Rola Nakhoul2, Michael Jerdev3, Roth Ana1, Farid Nakhoul1,4, Evgeny Farber1
1Nephrology & Hypertension Division and 3Department of Radiology, Baruch Padeh Poriya Medical Center, Tiberias, Israel; 2Szeged Faculty of Medicine, Szeged, Hungary; 4Azrieli Faculty of Medicine, Ramat Gan, Israel.
Corresponding Author:
Dr. Evgeny Farber
Email: Efarber@poria.health.gov.il
Received: 08-MAY-2017 Accepted: 05-JUL-2018 Published Online: 25-JUL-2018
DOI: http://dx.doi.org/10.17659/01.2018.0048
Abstract
Background: The number of patients with end stage renal disease (ESRD) who need renal replacement therapy to survive is increasing worldwide. Continuous ambulatory peritoneal dialysis (CAPD) is the preferred treatment to treat ESRD in an increasing number of patients. However, the long-term effectiveness of CAPD is limited by complications such as peritonitis. Encapsulating sclerosing peritonitis (ESP), a rare cause of bowel obstruction with high morbidity and mortality, was described as a complication associated with peritoneal dialysis. Case Report: Here we report a case where early abdominal CT in association with clinical symptoms allowed non-invasive diagnosis of ESP, and immediate steroid treatment successfully relieved the symptoms with excellent outcome. Conclusion: Early diagnosis and institution of corticosteroid therapy is effective treatment of encapsulating sclerosing peritonitis secondary to peritoneal dialysis.
Keywords : Peritoneal Dialysis, Peritoneal Fibrosis, Intestinal Obstruction, Ultrasonography, Computed Tomography.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports

abortion pill online

Secure abortion pill tablets. There he could simply order pill for abortion online generic.There we could simply order generic site.
Last updated on Apr 05, 2024